- £2.00bn
- £2.93bn
- £321.60m
- 49
- 28
- 67
- 43
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 171 | 193 | 271 | 307 | 322 |
Cost of Revenue | |||||
Gross Profit | 170 | 192 | 271 | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 125 | 143 | 201 | 189 | 243 |
Operating Profit | 45.4 | 49.9 | 70.3 | 119 | 78.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 47.5 | 48.5 | 62.6 | 127 | 86 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.9 | 47.7 | 57.8 | 121 | 70.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 28.9 | 36.5 | 57.8 | 121 | 70.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.9 | 36.5 | 57.8 | 121 | 70.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.035 | 0.053 | 0.102 | 0.15 | 0.136 |
Dividends per Share |